TYR-GLY-ALA-VAL-VAL-ASN-ASP-LEU

Modify Date: 2024-01-20 18:22:29

TYR-GLY-ALA-VAL-VAL-ASN-ASP-LEU structure	Common Name	TYR-GLY-ALA-VAL-VAL-ASN-ASP-LEU
	CAS Number	103424-74-4	Molecular Weight	849.92800
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₈H₅₉N₉O₁₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of TYR-GLY-ALA-VAL-VAL-ASN-ASP-LEU

Herpes virus inhibitor 2 is a herpes virus inhibitor and disrupts herpes virus ribonucleotide reductase quaternary structure. Herpes virus inhibitor 2 inhibits viral replication[1][2].

Name	2-[[2-[[4-amino-2-[[2-[[2-[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoic acid
Synonym	More Synonyms

Description	Herpes virus inhibitor 2 is a herpes virus inhibitor and disrupts herpes virus ribonucleotide reductase quaternary structure. Herpes virus inhibitor 2 inhibits viral replication[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Metabolic Enzyme/Protease >> HIV Protease
References	[1]. Dutia BM, et, al. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature. 1986 May 22-28;321(6068):439-41. [2]. Gaudreau P, et, al. Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase. J Biol Chem. 1987 Sep 15;262(26):12413-6.

Description

Herpes virus inhibitor 2 is a herpes virus inhibitor and disrupts herpes virus ribonucleotide reductase quaternary structure. Herpes virus inhibitor 2 inhibits viral replication[1][2].

Related Catalog

Research Areas >> Infection

Signaling Pathways >> Metabolic Enzyme/Protease >> HIV Protease

References

[1]. Dutia BM, et, al. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature. 1986 May 22-28;321(6068):439-41.

[2]. Gaudreau P, et, al. Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase. J Biol Chem. 1987 Sep 15;262(26):12413-6.